| |
NewswireTODAY - /newswire/ -
Monrovia, CA, United States, 2013/03/13 - Mostafa Ronaghi, Senior Vice President and Chief Technology Officer of Illumina Will Give a Keynote Presentation on “The New Era of Medicine Enabled by Advancing NextGen Sequencing” at GTC’s 3rd Next Generation Sequencing Conference on June 20 21, 20.
|
| |
|
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Mostafa Ronaghi will give a keynote presentation on “The New Era of Medicine Enabled by Advancing NextGen Sequencing” at GTC’s 3rd Next Generation Sequencing Conference on June 20 21, 2013 in San Francisco, CA.
The cost of DNA sequencing has been reduced by several orders of magnitude in the past decade. This dramatic reduction has enabled the scientific community to address an increasingly diverse range of biological problems. The scale and efficiency of sequencing that can now be achieved is providing unprecedented progress in areas from agriculture, forensics, consumer genetics and diagnostics. In his talk, Dr. Ronaghi will review recent progresses on Illumina's platforms. In addition, the use of next generation sequencing in molecular diagnostics will be discussed.
Dr. Ronaghi is currently the Senior Vice President and Chief Technology Officer of Illumina and is responsible for leading internal research programs and evaluating new technologies for the company. He is an experienced entrepreneur and was involved in the start-up of four life sciences companies. Mostafa holds more than 20 pending and issued patents and has written more than 50 peer-reviewed publications in journals and books.
The 3rd Next Generation Sequencing Conference is a forum for industry, academic and government leaders in the field to present on the current and future applications of the technology as well as share strategies, best practices and protocols on the usage of the tool. Hot topics that will be covered include clinical diagnostics development, the microbiome and infectious disease applications, bioinformatics and methods of data analysis, nanopore sequencing and other future sequencing technologies on the horizon.
This conference is part of the larger Nucleic Acid Summit, which includes the Bioinformatics & Data Management Strategies pre-conference workshop on June 19th and is co-located with the 4th RNAi Research & Therapeutics Conference.
|
| |
 |
| |
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
| |
Agency / Source: GTCbio - Biopharmaceutical Conference
|
| |
 |
| |
Availability: All Regions (Including Int'l)
|
| |
Traffic Booster: [/] Quick NewswireToday Visibility Checker
|
| |
Distribution / Indexing: [+]
|
| |
 |
| |
# # #
|
| |
|
| |
 |
| |
Your Banner Ad showing on ALL Pharma / BioTech / Nutrition articles, CATCH Visitors via Your Competitors Announcements!
 Company website links NOT available to basic submissions |
|
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source. |
| |
 |
| |
For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
| |
Contact: GTCbio.com
626-256-6405 infogtcbio[.]gtcbio.com
|